C. Kavadichanda

发表

Clinical and psychosocioeconomic impact of COVID-19 pandemic on patients of the Indian Progressive Systemic Sclerosis Registry (IPSSR)

C. Kavadichanda, V. Shobha, P. Ghosh, 2021, Rheumatology advances in practice.

APLAR recommendations on the practice of telemedicine in rheumatology

C. Kavadichanda, B. Masri, Sakir Ahmed, 2022, International journal of rheumatic diseases.

Impact of the COVID-19 pandemic on patients with systemic lupus erythematosus: Observations from an Indian inception cohort

C. Kavadichanda, V. Shobha, V. Negi, 2020, Lupus.

Factors associated with high cardiovascular risk in psoriatic arthritis and non-psoriatic spondyloarthritis

C. Kavadichanda, V. Negi, Sachit Ganapathy, 2022, Rheumatology International.

Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study

C. Kavadichanda, V. Negi, Latika Gupta, 2021, Rheumatology International.

Differentiating flare and infection in febrile lupus patients: Derivation and validation of a calculator for resource constrained settings

C. Kavadichanda, Komal Singh, L. Rajasekhar, 2022, Lupus.

De Novo Crohn's Disease Triggered After COVID-19: Is COVID-19 More Than an Infectious Disease?

C. Kavadichanda, P. Mohan, A. Hamide, 2021, ACG case reports journal.

Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network

C. Kavadichanda, Sakir Ahmed, Latika Gupta, 2021, Clinical Rheumatology.

Cultural adaptation, translation and validation of Cochin Hand Function Scale and evaluation of hand dysfunction in systemic sclerosis

C. Kavadichanda, D. Bairwa, V. Negi, 2020, Clinical Rheumatology.

Spondyloarthritis and the Human Leukocyte Antigen (HLA)-B*27 Connection

C. Kavadichanda, V. Negi, J. Geng, 2021, Frontiers in Immunology.

Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment

C. Kavadichanda, V. Negi, D. Danda, 2020, Rheumatology International.

COVAD survey 2 long-term outcomes: unmet need and protocol

M. Hudson, C. Caballero-Uribe, A. Tan, 2022, Rheumatology International.

Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States

C. Kavadichanda, Sakir Ahmed, Latika Gupta, 2021, Seminars in Arthritis and Rheumatism.

Tuberculosis in Children with Rheumatic Diseases Treated with Biologic Disease-Modifying Anti-Rheumatic Drugs

C. Kavadichanda, S. Ajmani, I. Maccora, 2021, Mediterranean journal of rheumatology.

Metabolic inflammatory volume and total inflammatory glycolysis: novel parameters to evaluate PET-CT disease activity in Takayasu arteritis

C. Kavadichanda, S. Gambhir, D. Misra, 2023, Clinical Rheumatology.

Effect of skin phototype on quantitative nailfold capillaroscopy

C. Kavadichanda, D. Bairwa, V. Negi, 2022, Journal of scleroderma and related disorders.

Clinical correlates of HLA‐B*27 and its subtypes in enthesitis‐related arthritis variant of juvenile idiopathic arthritis in south Indian Tamil patients

C. Kavadichanda, V. Negi, G. Kumar, 2019, International journal of rheumatic diseases.

COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis

C. Kavadichanda, Sakir Ahmed, Hiba Khan, 2022, Seminars in Arthritis and Rheumatism.

Tele-rheumatology for overcoming socioeconomic barriers to healthcare in resource constrained settings: lessons from COVID-19 pandemic

A. Mathew, C. Kavadichanda, D. Bairwa, 2020, Rheumatology.

Management of Takayasu arteritis.

C. Kavadichanda, D. Misra, V. Agarwal, 2023, Best practice & research. Clinical rheumatology.

Severe thrombocytopenia is associated with high mortality in systemic lupus erythematosus-analysis from Indian SLE Inception cohort for Research (INSPIRE).

C. Kavadichanda, V. Shobha, M. Rathi, 2023, Clinical rheumatology.

Clinical and serological association of plasma 25-hydroxyvitamin D (25(OH)D) levels in lupus and the short-term effects of oral vitamin D supplementation

C. Kavadichanda, V. Negi, A. Aggarwal, 2023, Arthritis Research & Therapy.

Pathogenesis of muscle weakness in inflammatory myositis

C. Kavadichanda, T. Sundaram, S. Dunga, 2020 .

COVID-19 vaccination in autoimmune disease (COVAD) survey protocol

A. Tan, E. Bocci, C. Kavadichanda, 2021, Rheumatology International.

Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey

M. Hudson, A. Tan, E. Bocci, 2023, Rheumatology International.

Performance of Clinical and Biochemical Parameters in Identifying Renal Histopathology and Predictors of One-Year Renal Outcome in Lupus Nephritis—A Single Centre Study from India

C. Kavadichanda, D. Bairwa, V. Negi, 2022, Diagnostics.

Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network

C. Kavadichanda, Sakir Ahmed, Latika Gupta, 2021, Journal of Autoimmunity.

Early onset neutropenia and thrombocytopenia following rituximab in lupus nephritis

C. Kavadichanda, V. Negi, R. Ganesh, 2018, International journal of rheumatic diseases.

Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial

C. Kavadichanda, V. Negi, P. Belani, 2021, Rheumatology International.

Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.

A. Tomelleri, C. Campochiaro, E. Baldissera, 2023, Rheumatology.

High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey

M. Hudson, A. Tan, E. Bocci, 2022, Rheumatology International.

Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study

C. Caballero-Uribe, A. Tan, E. Bocci, 2023, Rheumatology International.

Journal metrics: Different from author metrics

C. Kavadichanda, 2020 .

Management of Takayasu arteritis.

C. Kavadichanda, D. Misra, V. Agarwal, 2023, Best practice & research. Clinical rheumatology.

Synovial‐fluid‐derived microparticles express vimentin and GRP78 in their surface and exhibit an in vitro stimulatory effect on fibroblast‐like synoviocytes in rheumatoid arthritis

C. Kavadichanda, V. Negi, C. Mariaselvam, 2023, International journal of rheumatic diseases.

Can we further SPARkle the SPAR model?

C. Kavadichanda, V. Negi, 2018, Annals of the rheumatic diseases.

Role of [68Ga]-pentixafor positron emission tomography/computed tomography imaging in assessing disease activity in patients with lupus nephritis: A pilot study.

C. Kavadichanda, Nandini Pandit, Ahalya Nair, 2023, Lupus.

COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis.

M. Hudson, A. Tan, E. Bocci, 2022, Rheumatology.

Exploratory clinical subgroup clustering in systemic sclerosis: Results from the Indian Progressive Systemic Sclerosis Registry.

C. Kavadichanda, V. Shobha, A. Wakhlu, 2023, Journal of Scleroderma and Related Disorders.

POS0708 VALIDATION OF THE REVISED 2022 AMERICAN COLLEGE OF RHEUMATOLOGY/ EULAR CLASSIFICATION CRITERIA FOR TAKAYASU ARTERITIS

A. Tomelleri, E. Baldissera, L. Dagna, 2023, Annals of the Rheumatic Diseases.

Low C4A copy numbers and higher HERV gene insertion contributes to increased risk of SLE, with absence of association with disease phenotype and disease activity.

C. Kavadichanda, M. Thabah, W. Boukouaci, 2024, Immunologic research.

Rheumatoid arthritis autologous synovial fluid affects the plasticity and function of peripheral and induced T regulatory cells in vitro.

C. Kavadichanda, M. Thabah, C. Mariaselvam, 2024, Immunology letters.

Expert Panel Consensus Statements on Vaccination for Adults with AIRD in India

C. Kavadichanda, B. Dharmanand, K. Mohanasundaram, 2024, Indian Journal of Rheumatology.